The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.

To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes.We studied the relationship between baseline, updated mean and upd...

Full description

Bibliographic Details
Main Authors: Marcus Lind, Jaakko Tuomilehto, Matti Uusitupa, Olle Nerman, Johan Eriksson, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Markku Peltonen, Aldina Pivodic, Jaana Lindström
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4186853?pdf=render
_version_ 1819259707248869376
author Marcus Lind
Jaakko Tuomilehto
Matti Uusitupa
Olle Nerman
Johan Eriksson
Pirjo Ilanne-Parikka
Sirkka Keinänen-Kiukaanniemi
Markku Peltonen
Aldina Pivodic
Jaana Lindström
author_facet Marcus Lind
Jaakko Tuomilehto
Matti Uusitupa
Olle Nerman
Johan Eriksson
Pirjo Ilanne-Parikka
Sirkka Keinänen-Kiukaanniemi
Markku Peltonen
Aldina Pivodic
Jaana Lindström
author_sort Marcus Lind
collection DOAJ
description To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes.We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study.Follow-up of clinical trial.504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c.Relative risk of CVD.Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p<0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD.Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes.
first_indexed 2024-12-23T19:14:17Z
format Article
id doaj.art-3f8b208bdd004b159bfa90d00c94cedf
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T19:14:17Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-3f8b208bdd004b159bfa90d00c94cedf2022-12-21T17:34:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10950610.1371/journal.pone.0109506The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.Marcus LindJaakko TuomilehtoMatti UusitupaOlle NermanJohan ErikssonPirjo Ilanne-ParikkaSirkka Keinänen-KiukaanniemiMarkku PeltonenAldina PivodicJaana LindströmTo determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes.We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study.Follow-up of clinical trial.504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c.Relative risk of CVD.Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p<0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD.Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes.http://europepmc.org/articles/PMC4186853?pdf=render
spellingShingle Marcus Lind
Jaakko Tuomilehto
Matti Uusitupa
Olle Nerman
Johan Eriksson
Pirjo Ilanne-Parikka
Sirkka Keinänen-Kiukaanniemi
Markku Peltonen
Aldina Pivodic
Jaana Lindström
The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
PLoS ONE
title The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
title_full The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
title_fullStr The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
title_full_unstemmed The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
title_short The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
title_sort association between hba1c fasting glucose 1 hour glucose and 2 hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes
url http://europepmc.org/articles/PMC4186853?pdf=render
work_keys_str_mv AT marcuslind theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT jaakkotuomilehto theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT mattiuusitupa theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT ollenerman theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT johaneriksson theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT pirjoilanneparikka theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT sirkkakeinanenkiukaanniemi theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT markkupeltonen theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT aldinapivodic theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT jaanalindstrom theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT marcuslind associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT jaakkotuomilehto associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT mattiuusitupa associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT ollenerman associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT johaneriksson associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT pirjoilanneparikka associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT sirkkakeinanenkiukaanniemi associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT markkupeltonen associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT aldinapivodic associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT jaanalindstrom associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes